INSIGHTS ON DRUG DEVELOPMENT
-
![DNA Helix GettyImages-1421515036]( "Improving Gene Therapy Development With Organ-On-A-Chip Technology")
Improving Gene Therapy Development With Organ-On-A-Chip TechnologyExplore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.
-
![iStock-1191189866-lung-inhalation-skeleton-respiratory]( "Expanding Opportunities For Inhaled Drug Delivery")
Expanding Opportunities For Inhaled Drug DeliveryReview the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.
-
![GettyImages-1691974990-exosome-3d-render-cell]( "Exosome Production From hMSC Using A Fixed-Bed Bioreactor")
Exosome Production From hMSC Using A Fixed-Bed BioreactorExplore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
![Antibodies And Proteins GettyImages-1364886992]( "Innovating The mAb Characterization Process")
Innovating The mAb Characterization ProcessUnderstanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.
-
A CDMO Is The Nexus Between Green Chemistry And Commercialization2/24/2026
Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.
-
Modeling Virus Evolution, Rapid Drug Repurposing With Human Airway Lung-Chips8/2/2024
In this presentation, we introduce the human Airway Lung-Chip, which can model influenza virus infection and evolution in vitro and evaluate therapeutics for both influenza and SARS-CoV-2.
-
Automating High-Throughput Screens Using Patient-Derived Organoids3/17/2025
Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow11/7/2025
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
Improved Cell Viability For Multi-Day Cell-Based Assays7/24/2025
Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-ez4-hero]( "Educational Stereo Microscope For Beginners In College And University")
Leica EZ
The Leica EZ4 educational stereomicroscope with 4.4:1 zoom for entry level university and college courses such as biology, anatomy and chemistry provides over 20 years of bright LED illumination which saves time and cost of replacement bulbs.
-
![Samsung]( "The Power Of One: mRNA Services")
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.
-
![Corporate Brochure visual 8]( "Trusted End-To-End CDMO Partner For Your Journey")
Partner with a trusted, globally proven CDMO whose world-class, rapidly scalable facilities and unwavering commitment to quality help accelerate patient access to life-saving biologics.
-
![Carl Zeiss Microscope]( "Used Carl Zeiss Microscope")
Used Carl Zeiss Microscope, with AxioCam MRc5 and H.I.P controls, CE design, serial# 39180008000.
-
![How SimpleStep ELISA Works]( "Sandwich ELISA Assays For Unparalleled Simplicity And Effectiveness")
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.
